Insider Transactions in Q1 2021 at Biolife Solutions Inc (BLFS)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 26
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
2,120
-2.83%
|
$74,200
$35.01 P/Share
|
|
Mar 26
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
2,893
-1.62%
|
$101,255
$35.01 P/Share
|
|
Mar 26
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
3,809
-1.52%
|
$133,315
$35.01 P/Share
|
|
Mar 26
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
2,562
-3.77%
|
$89,670
$35.01 P/Share
|
|
Mar 26
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,016
-1.48%
|
$105,560
$35.01 P/Share
|
|
Mar 25
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-5.29%
|
$370,000
$37.71 P/Share
|
|
Mar 25
2021
|
Roderick De Greef President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.02%
|
$10,000
$1.81 P/Share
|
|
Mar 24
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-5.29%
|
$400,000
$40.18 P/Share
|
|
Mar 24
2021
|
Roderick De Greef President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.02%
|
$10,000
$1.81 P/Share
|
|
Mar 24
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.67%
|
$400,000
$40.18 P/Share
|
|
Mar 24
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.46%
|
$10,000
$1.64 P/Share
|
|
Mar 23
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-5.29%
|
$410,000
$41.83 P/Share
|
|
Mar 23
2021
|
Roderick De Greef President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.02%
|
$10,000
$1.81 P/Share
|
|
Mar 22
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
16,332
-19.37%
|
$604,284
$37.56 P/Share
|
|
Mar 22
2021
|
Karen A. Foster Chief Quality and Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
16,332
+16.23%
|
$16,332
$1.64 P/Share
|
|
Mar 22
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.67%
|
$370,000
$37.8 P/Share
|
|
Mar 22
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.46%
|
$10,000
$1.64 P/Share
|
|
Mar 16
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,160
-7.6%
|
$221,760
$36.72 P/Share
|
|
Mar 16
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+7.07%
|
$6,160
$1.64 P/Share
|
|
Mar 15
2021
|
Andrew G Hinson Director |
SELL
Open market or private sale
|
Direct |
2,500
-7.66%
|
$92,500
$37.32 P/Share
|
|
Mar 15
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,160
-7.6%
|
$221,760
$36.91 P/Share
|
|
Mar 15
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+7.07%
|
$6,160
$1.64 P/Share
|
|
Feb 26
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
403
-0.2%
|
$15,717
$39.57 P/Share
|
|
Feb 26
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
284
-0.42%
|
$11,076
$39.57 P/Share
|
|
Feb 26
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
861
-0.34%
|
$33,579
$39.57 P/Share
|
|
Feb 22
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
16,334
-19.31%
|
$637,026
$39.66 P/Share
|
|
Feb 22
2021
|
Karen A. Foster Chief Quality and Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
16,334
+16.18%
|
$16,334
$1.64 P/Share
|
|
Feb 19
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
4,509
-2.46%
|
$180,360
$40.76 P/Share
|
|
Feb 19
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
1,876
-2.44%
|
$75,040
$40.76 P/Share
|
|
Feb 19
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
10,107
-3.87%
|
$404,280
$40.76 P/Share
|
|
Feb 19
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,728
-2.26%
|
$189,120
$40.76 P/Share
|
|
Feb 19
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
3,344
-4.67%
|
$133,760
$40.76 P/Share
|
|
Feb 18
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
4,520
-2.4%
|
$180,800
$40.67 P/Share
|
|
Feb 18
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
1,882
-2.39%
|
$75,280
$40.67 P/Share
|
|
Feb 18
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
10,132
-3.73%
|
$405,280
$40.67 P/Share
|
|
Feb 18
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,741
-2.22%
|
$189,640
$40.67 P/Share
|
|
Feb 18
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
3,353
-4.47%
|
$134,120
$40.67 P/Share
|
|
Feb 17
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
4,424
-2.3%
|
$181,384
$41.55 P/Share
|
|
Feb 17
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
1,842
-2.29%
|
$75,522
$41.55 P/Share
|
|
Feb 17
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
9,917
-3.52%
|
$406,597
$41.55 P/Share
|
|
Feb 17
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,640
-2.12%
|
$190,240
$41.55 P/Share
|
|
Feb 17
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
3,281
-4.19%
|
$134,521
$41.55 P/Share
|
|
Feb 16
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
12,324
-8.8%
|
$542,256
$44.48 P/Share
|
|
Feb 16
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,324
+8.09%
|
$12,324
$1.64 P/Share
|
|
Feb 16
2021
|
Andrew G Hinson Director |
SELL
Open market or private sale
|
Direct |
2,500
-12.85%
|
$112,500
$45.67 P/Share
|
|
Feb 08
2021
|
Roderick De Greef President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
31,552
+14.08%
|
-
|
|
Feb 08
2021
|
Roderick De Greef President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,740
+2.86%
|
-
|
|
Feb 08
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,982
+13.89%
|
-
|
|
Feb 08
2021
|
Todd Berard Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,610
+5.08%
|
-
|
|
Feb 08
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
70,994
+20.15%
|
-
|